PUBLICACIÓN

Vaccination schedule for adolescents. Consensus of the AEV, CAV-AEP and SEMA

Logo Open Access

ACCEDER A LA PUBLICACIÓN: Scopus Dialnet

Alvarez Garcia F.J., Grande Tejada A.M., Guemes Heras I., Iofrio de Arce A., Moraga Llop F., Notario Herreros F., Perez Martin J.J., Serrano Marchuet P., Valdes Rodriguez J.

2023 ANALES DE PEDIATRIA

Pediatrics, Perinatology and Child Health (Q3)

JCR: 1.5

SJR: 0.289

CITAS

2

DOI

10.1016/j.anpedi.2023.05.009

EID

2-s2.0-85162204500

ISSN

1695-4033

EISSN

1695-9531

AUTORES DE LA UEX

Ana María Grande Tejada

OTRAS PUBLICACIONES DE INTERÉS

Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Impact Of Current Influenza Vaccination Recommendations In Risk Groups
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Vaccination Schedule For Adolescents. Consensus Of The Aev, Cav-Aep And Sema
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Pleural Effusion In A Child With A Correctly Placed Ventricle-Peritoneal Shunt
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Epidemiology, Prevention And Control Of Pertussis In Spain: New Vaccination Strategies For Lifelong Protection
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Management And Monitoring Of Patients With Duchenne Disease
Recovering Lost Vaccine Coverage Due To Covid-19 Pandemic
Management And Monitoring Of Patients With Duchenne Disease
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Management And Monitoring Of Patients With Duchenne Disease
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Erratum: Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs (Vacunas (2015) 16, 1:6-11))
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Estimate Of The Impact Of Influenza Vaccination With Adjuvant Mr59 In Population Over 64 Years For The National Health System: Effects And Costs
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Safety And Immunogenicity Of 13-Valent Pneumococcal Conjugate Vaccine In Infants: A Meta-Analysis
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Assessment Of The Mf59-Adjuvanted Pandemic Influenza A/h1n1 Vaccine. Systematic Review Of Literature
Early Response To Idursulfase Treatment In A 3 Year-Old Boy Affected Of Hunter Syndrome
Antiviral Treatment And Risk Of Hearing Loss In Asymptomatic And Mild Symptomatic Infants With Congenital Cytomegalovirus
WEB ACCESIBLE